|
| Issue Date | Title | Author(s) |
| Jun-2024 | Advances in the discovery of activin receptor-like kinase 5 (ALK5) inhibitors | Mansour, Mai A; Hassan, Ghaneya S; Jaballah, Maiy Y; Abouzid, Khaled A M; Serya, Rabah |
| 1-Jul-2025 | Design and synthesis of novel Hydroxamate and non-Hydroxamate HDAC inhibitors based on Chromone and Quinazolone scaffolds | Ashraf, Rosaline; Adel, Mai; Ibrahim, Esraa; Haffez, Hesham; Soror, Sameh; Abouzid, Khaled A M; Serya, Rabah |
| 20-Jan-2018 | Discovery of anilino-furo[2,3-d]pyrimidine derivatives as dual inhibitors of EGFR/HER2 tyrosine kinase and their anticancer activity | Hossam, Monia; Ahmed Esmat ; Mansour, Ahmed M; Abouzid, Khaled A M; Singab A. |
| Sep-2025 | Discovery of Furopyrimidine-Pyrazole Hybrid Compounds Targeting p53-MDM2 Interaction as Anticancer Agents | Mansour, Mai A; Hassan, Ghaneya S; Jaballah, Maiy Y; Dege, Necmi; Şahin, Onur; Sharaky, Marwa; Zhang, Xiaoliang; Su, Ruixin; Kong, Dexin; Abouzid, Khaled A M; Serya, Rabah |
| 15-Dec-2017 | How to train your inhibitor: Design strategies to overcome resistance to Epidermal Growth Factor Receptor inhibitors | Milik, Sandra N; Lasheen, Deena S; Serya, Rabah ; Abouzid, Khaled A M; Khaled A M Abouzid |
| Mar-2022 | Identification of a promising hit from a new series of pyrazolo[1,5-a]pyrimidine based compounds as a potential anticancer agent with potent CDK1 inhibitory and pro-apoptotic properties through a multistep in vitro assessment | Elgiushy, Hossam R; Mohamed, Sameh H; Sawaf, Hussein; Hassan, Zeinab; Abou-Taleb, Nageh A; El-Labbad, Eman M; Hassan, Ashraf S; Abouzid, Khaled A M; Abouzid, Khaled ; Ali Taha, Heba |
| May-2026 | Ligand-Based Design of Novel Thiazole-Quinazolinone Hybrids with Dual Antimicrobial and Anti-Virulence Activity Targeting Staphylococcal Sortase A | Hammad, Shaymaa G; Aboul-Magd, Dina S; Ghorab, Mostafa M; Adel, Mai; Serya, Rabah ; El-Hossary, Ebaa M; El-Gazzar, Marwa G; Abouzid, Khaled A M |
| 22-Dec-2022 | SAR investigation and optimization of benzimidazole-based derivatives as antimicrobial agents against Gram-negative bacteria | Dokla, Eman ; Abutaleb, Nader S; Milik, Sandra N; Kandil, Ezzat A E A; Qassem, Omar M; Elgammal, Yehia; Nasr, Maha ; McPhillie, Martin J; Abouzid, Khaled A M; Seleem, Mohamed N; Imming, Peter; Adel, Mai |
| May-2025 | Structural Optimization and MD Simulation Study of Benzimidazole Derivatives as Potent Mutant FLT3 Kinase Inhibitors Targeting AML | El-Deen, Nada Alaa; DeFilippis, RosaAnna; Milik, Sandra N; Patel, Suhana; Ismail, Muhammad I; Khaled, Omar; Ahmed, Tarek Erfan; Abdelfattah, Ayatullah Gamal; Ali, Eslam M H; Gaballah, Maiy Y; McPhillie, Martin J; Abouzid, Khaled A M; Henary, Maged; Minucci, Saverio; Shah, Neil P; Abdel-Aziz, Amal Kamal ; Serya, Rabah ; Dokla, Eman |
| 2020 | Synthesis and in-vitro anti-proliferative evaluation of some pyrazolo[1,5-a]pyrimidines as novel larotrectinib analogs | Attia, Mohamed H; Elrazaz, Eman ; El-Emam, Soad Z; Taher, Azza T; Abdel-Aziz, Hatem A; Abouzid, Khaled A M |
| 1-Dec-2025 | Tackling microbial resistance with 4H-chromen-4-one derivatives as a novel class of penicillin binding protein 2a inhibitors | Shalaby, Menna-Allah W; Abutaleb, Nader S; Elgammal, Yehia; Liang, Hsin-Wen; Abdallah, Inas A; Fishovitz, Jennifer; Seleem, Mohamed N; Abouzid, Khaled A M; Serya, Rabah ; Dokla, Eman |
| 1-Jul-2025 | Targeting DNA repair mechanisms: Spirobenzoxazinone and salicylamide derivatives as novel candidates for PARP-1 inhibition in cancer therapy | Kadry, Alaa Ahmed; Adel, Mai; Abubshait, Samar A; Yahya, Galal; Sharaky, Marwa; Abouzid, Khaled A M; Serya, Rabah |
